Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Benson

Showing results (811-820 of 865) with videos related to

Pageof 87
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphomaKhuda D Khan, Christos Emmanouilides, Don M Benson, et al.
Immunity|May 23, 2006
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cellsJianhua Yu, Min Wei, Brian Becknell, et al.
Molecular Cancer|June 26, 2010
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activityMatthew A Bill, James R Fuchs, Chenglong Li, et al.
Blood|November 18, 2006
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cellsBrian Becknell, Tiffany L Hughes, Aharon G Freud, et al.
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
The Journal of Clinical Investigation|March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and humanJianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 26, 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic MalignancyAshley E Rosko, Sarah Wall, Robert Baiocchi, et al.
Journal of Molecular Biology|October 20, 2019
Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand DiseaseAlexander Tischer, Maria A Brehm, Venkata R Machha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host DiseaseSumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Pageof 87

Showing results (811-820 of 865) with videos related to

Sort By:
Pageof 87
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphomaKhuda D Khan, Christos Emmanouilides, Don M Benson, et al.
Immunity|May 23, 2006
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cellsJianhua Yu, Min Wei, Brian Becknell, et al.
Molecular Cancer|June 26, 2010
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activityMatthew A Bill, James R Fuchs, Chenglong Li, et al.
Blood|November 18, 2006
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cellsBrian Becknell, Tiffany L Hughes, Aharon G Freud, et al.
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
The Journal of Clinical Investigation|March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and humanJianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 26, 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic MalignancyAshley E Rosko, Sarah Wall, Robert Baiocchi, et al.
Journal of Molecular Biology|October 20, 2019
Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand DiseaseAlexander Tischer, Maria A Brehm, Venkata R Machha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host DiseaseSumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Pageof 87